Scientific Reference
DSIP (Delta Sleep-Inducing Peptide)
Evidence profile: Controlled human evidence
DSIP (Delta Sleep-Inducing Peptide) is a naturally occurring nonapeptide originally isolated from the brain in 1974, composed of nine amino acids. It was initially identified for its role in promoting delta-wave (deep) sleep, but subsequent research has revealed broader neuromodulatory effects, including stress regulation, endocrine modulation, and potential analgesic properties. Despite decades of investigation, its precise mechanisms remain incompletely understood. However, DSIP is widely studied for its ability to enhance sleep architecture without traditional sedative effects, making it of interest in sleep optimization, recovery, and neuroendocrine regulation.
Published Research
Acute and delayed effects of DSIP (delta sleep-inducing peptide) on human sleep behavior
Schneider-Helmert D et al. · International journal of clinical pharmacology, therapy, and toxicology · 1981 · Clinical
PMID 6895513 — View on PubMedThe influence of synthetic DSIP (delta-sleep-inducing-peptide) on disturbed human sleep
Schneider-Helmert D et al. · Experientia · 1981 · Clinical
PMID 7028502 — View on PubMed